127 related articles for article (PubMed ID: 11565329)
21. Angiotensin II receptor blockers in chronic heart failure--not as ELITE as expected!
Farquharson CA; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):21-2. PubMed ID: 11967790
[TBL] [Abstract][Full Text] [Related]
22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense?
Hennig L
Clin Nephrol; 2002 Jul; 58 Suppl 1():S7-11. PubMed ID: 12227730
[TBL] [Abstract][Full Text] [Related]
24. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
25. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
Stern N; Grossman E; ; ; ;
Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
[TBL] [Abstract][Full Text] [Related]
26. [Renin-angiotensin system modulation: instructions for use].
Bellis A; Rozza F; Crispo S; Trimarco B
G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
[TBL] [Abstract][Full Text] [Related]
27. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
Sica DA
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
29. [ACE inhibitor or AT1 antagonist. Is there a differential therapy?].
Unger T; Rangoonwala B; Rosenthal J
MMW Fortschr Med; 2002 Jun; 144(24):36-8. PubMed ID: 12134723
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin converting enzyme inhibitors in perspective: an update.
Burrell LM; Johnston CI
Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve.
Stanley JC; Samson RH
Semin Vasc Surg; 2002 Dec; 15(4):225-36. PubMed ID: 12478497
[TBL] [Abstract][Full Text] [Related]
33. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
34. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
35. [Are non blood pressure effects of converting enzyme inhibitors important in arterial hypertension?].
Gosse P; Guillo P; Dallocchio M
Rev Prat; 1992 Dec; 42(20):2539-43. PubMed ID: 1299937
[TBL] [Abstract][Full Text] [Related]
36. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
[TBL] [Abstract][Full Text] [Related]
37. A hard look at angiotensin receptor blockers in heart failure.
Gring CN; Francis GS
J Am Coll Cardiol; 2004 Nov; 44(9):1841-6. PubMed ID: 15519017
[TBL] [Abstract][Full Text] [Related]
38. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
39. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
[No Abstract] [Full Text] [Related]
40. Renin-angiotensin system modulation: the weight of evidence.
Brown B; Hall AS
Am J Hypertens; 2005 Sep; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
